Header cover image

Swedish (OMX) Medical Equipment Industry Analysis

UpdatedJul 16, 2024
DataAggregated Company Financials
Companies60
  • 7D2.3%
  • 3M-1.2%
  • 1Y3.2%
  • YTD-5.3%

Over the last 7 days, the Medical Equipment industry has risen 2.3%, driven by gains from Xvivo Perfusion of 22%. This takes the industry's 12 month performance to a gain of 3.2%. As for the next few years, earnings are expected to grow by 25% per annum.

Industry Valuation and Performance

Has the Swedish Medical Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 16 Jul 2024SEK 165.7bSEK 73.1bSEK 2.7b30.7x62.3x2.3x
Thu, 13 Jun 2024SEK 160.8bSEK 72.8bSEK 2.6b30.5x61x2.2x
Sat, 11 May 2024SEK 169.7bSEK 73.0bSEK 2.7b31.8x61.8x2.3x
Mon, 08 Apr 2024SEK 167.8bSEK 72.2bSEK 2.6b32.3x65.4x2.3x
Wed, 06 Mar 2024SEK 158.6bSEK 72.2bSEK 2.4b32.4x65.7x2.2x
Fri, 02 Feb 2024SEK 167.6bSEK 73.1bSEK 1.9b45.9x90.5x2.3x
Sun, 31 Dec 2023SEK 173.9bSEK 71.4bSEK 1.5b41x113.5x2.4x
Tue, 28 Nov 2023SEK 164.3bSEK 70.0bSEK 1.3b35x129.4x2.3x
Thu, 26 Oct 2023SEK 141.5bSEK 69.7bSEK 1.2b25.8x117.1x2x
Sat, 23 Sep 2023SEK 150.3bSEK 68.8bSEK 1.1b31.3x138.3x2.2x
Mon, 21 Aug 2023SEK 154.3bSEK 68.2bSEK 831.6m30.5x185.6x2.3x
Wed, 19 Jul 2023SEK 160.6bSEK 67.5bSEK 733.0m34x219.1x2.4x
Fri, 16 Jun 2023SEK 180.4bSEK 66.9bSEK 1.3b34x134.3x2.7x
Sun, 14 May 2023SEK 178.0bSEK 65.8bSEK 1.4b37.1x126.5x2.7x
Tue, 11 Apr 2023SEK 177.6bSEK 64.1bSEK 1.4b36.1x129.8x2.8x
Thu, 09 Mar 2023SEK 165.4bSEK 63.7bSEK 1.7b39.6x98x2.6x
Sat, 04 Feb 2023SEK 183.7bSEK 62.7bSEK 2.0b33.3x92.8x2.9x
Mon, 02 Jan 2023SEK 159.5bSEK 61.8bSEK 2.3b26.7x68.8x2.6x
Wed, 30 Nov 2022SEK 167.2bSEK 61.8bSEK 2.4b28.4x69.7x2.7x
Fri, 28 Oct 2022SEK 164.5bSEK 60.4bSEK 2.8b27.2x59x2.7x
Sun, 25 Sep 2022SEK 148.3bSEK 59.7bSEK 2.8b25.9x53.8x2.5x
Tue, 23 Aug 2022SEK 176.9bSEK 58.8bSEK 2.8b34.7x64.1x3x
Thu, 21 Jul 2022SEK 180.1bSEK 58.7bSEK 2.6b33.4x68.3x3.1x
Sat, 18 Jun 2022SEK 183.1bSEK 58.4bSEK 3.0b35x61.9x3.1x
Mon, 16 May 2022SEK 214.1bSEK 57.5bSEK 2.9b52.4x73.4x3.7x
Wed, 13 Apr 2022SEK 250.2bSEK 56.8bSEK 3.1b65x80.6x4.4x
Fri, 11 Mar 2022SEK 230.5bSEK 56.6bSEK 3.6b44.9x63.2x4.1x
Sun, 06 Feb 2022SEK 272.6bSEK 56.2bSEK 3.6b59x75.2x4.8x
Tue, 04 Jan 2022SEK 309.8bSEK 56.9bSEK 3.8b60.3x80.5x5.4x
Thu, 02 Dec 2021SEK 299.6bSEK 56.9bSEK 3.8b57.6x78x5.3x
Sat, 30 Oct 2021SEK 297.3bSEK 56.3bSEK 3.9b75.3x76.3x5.3x
Mon, 27 Sep 2021SEK 302.4bSEK 57.8bSEK 4.4b80.3x68.3x5.2x
Wed, 25 Aug 2021SEK 299.4bSEK 57.8bSEK 4.4b71.3x67.3x5.2x
Price to Earnings Ratio

71.9x


Total Market Cap: SEK 319.7bTotal Earnings: SEK 4.4bTotal Revenue: SEK 57.8bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Medical Equipment Industry Price to Earnings3Y Average 90.1x202220232024
Current Industry PE
  • Investors are pessimistic on the Swedish Medical Equipment industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 62.3x which is lower than its 3-year average PE of 90.1x.
  • The 3-year average PS ratio of 3.2x is higher than the industry's current PS ratio of 2.3x.
Past Earnings Growth
  • The earnings for companies in the Medical Equipment industry have declined 16% per year over the last three years.
  • Meanwhile revenues for these companies have grown 8.2% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market1.85%
Healthcare1.54%
Medical Equipment2.25%
Medical Supplies9.11%
Medical Equipment0.36%
Industry PE
  • Investors are most optimistic about the Medical Equipment industry even though it's trading below its 3-year average PE ratio of 65.7x.
    • Analysts are expecting annual earnings growth of 16.8%, which is lower than the prior year's growth of 39.7% per year.
Forecasted Growth
  • Analysts are most optimistic on the Medical Supplies industry, expecting annual earnings growth of 52% over the next 5 years.
  • However this is lower than its past earnings growth rate of 344% per year.
  • In contrast, the Medical Equipment industry is expected to see its earnings grow by 17% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
XVIVO Xvivo PerfusionSEK 510.0021.9%
+SEK 2.9b
76.8%PE133.1x
CEVI CellaVisionSEK 271.004.2%
+SEK 262.4m
45.9%PE45.8x
SEDANA Sedana MedicalSEK 27.8010.1%
+SEK 253.3m
27.5%PS16.7x
VIMIAN Vimian GroupSEK 35.551.3%
+SEK 235.1m
35.7%PE202.5x
IMP A SDB ImplanticaSEK 37.701.3%
+SEK 141.6m
110.1%PS544.3x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

CARE

SEK 35.20

Careium

7D

14.7%

1Y

113.3%

XVIVO

SEK 510.00

Xvivo Perfusion

7D

21.9%

1Y

76.8%

QLINEA

SEK 3.56

Q-linea

7D

-11.6%

1Y

22.8%

IMP A SDB

SEK 37.70

Implantica

7D

1.3%

1Y

110.1%

EKTA B

SEK 67.00

Elekta

7D

-1.0%

1Y

-19.9%

LUMITO

SEK 1.21

Lumito

7D

-6.4%

1Y

-39.0%

VIMIAN

SEK 35.55

Vimian Group

7D

1.3%

1Y

35.7%

PRLD

SEK 0.24

Prolight Diagnostics

7D

-10.9%

1Y

-79.9%

SEZI

SEK 7.11

Senzime

7D

-5.7%

1Y

32.4%

INTEG B

SEK 54.20

Integrum

7D

-8.1%

1Y

216.6%

SEDANA

SEK 27.80

Sedana Medical

7D

10.1%

1Y

27.5%

ORT B

SEK 11.20

Ortoma

7D

30.5%

1Y

56.0%

SPEC

SEK 2.13

SpectraCure

7D

-9.2%

1Y

-64.9%